Pmda - Pharmaceuticals and Medical Devices Agency

Jump to body

Navigation of each product type

Our recommended contents

Navigation of each product type

Our recommended contents

日本語ページはこちら

Home
Regulatory Science/The Science Board/Standard Development
Standard Development
Japanese Pharmacopoeia
Pharmacopoeial Harmonization
PDG Press Release / News

Here begins the text.

PDG Press Release / News

Regulatory Science/The Science Board/Standard Development

Regulatory Science
The Science Board
- Outline
- The Science Board
- Outcome Documents of the Science Board
- Subcommittees (2019 December-)
  - Subcommittee on Computer Simulation
  - Subcommittee on Microbiome
- The Fourth Term Subcommittees (-2019 November)
  - Subcommittee on AMR
  - Subcommittee on Genome Editing
- The Third Term (- 2018 March) Subcommittees
  - Subcommittee on Rare Cancers
  - Subcommittee on Pharmaceuticals Development
  - Subcommittee on AI (Artificial Intelligence)
- The Second Term (- 2016 March) Subcommittees
  - Subcommittee on Placebo-controlled Studies
  - Subcommittee on Non-clinical Studies
  - Subcommittee on Application of Numerical Analysis to Non-clinical Evaluation
  - Subcommittee on Evaluation of Medical Devices in Pediatric Use
  - CPC (Cell Processing Center) Subcommittee
- The First Term (- 2014 March) Subcommittees
  - Pharmaceuticals Subcommittee
  - Medical Devices Subcommittee
  - Bio-products Subcommittee
  - Cellular and Tissue-based Products Subcommittee
Standard Development

Pmda - Pharmaceuticals and Medical Devices Agency

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.

000042617

0

PDG Press Release / News

/english/rs-sb-std/standards-development/jp/0014.html

en